SCHEMBL20788019

SCHEMBL20788019

CCCCC/C=C\C/C=C\CCCCCCCC(=O)Oc1cccc(/C=C/C(=O)O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.52
▸ KDM4E B2RXH2 3/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ AKR1C3 P42330 3/20 0.50
▸ AKR1C2 P52895 1/20 0.50
▸ FAAH O00519 1/20 0.48
▸ EPHX2 P34913 1/20 0.48
▸ POLM Q9NP87 1/20 0.47
▸ POLK Q9UBT6 1/20 0.47
▸ POLL Q9UGP5 1/20 0.47
▸ POLH Q9Y253 1/20 0.47
▸ PPARA Q07869 4/20 0.46
▸ F7 P08709 3/20 0.46
▸ F3 P13726 3/20 0.46
▸ PPARG P37231 2/20 0.46
▸ PPARD Q03181 2/20 0.46
▸ DUSP3 P51452 1/20 0.46
▸ PTPN7 P35236 1/20 0.46
▸ FFAR1 O14842 1/20 0.46
▸ LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20788020 1.00 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2AKR1C3AKR1C2
SCHEMBL20788032 0.92 ALDH1A1 (0.60) ALDH1A1KDM4ESMN1; SMN2AKR1C3AKR1C2
SCHEMBL20788033 0.92 ALDH1A1 (0.60) ALDH1A1KDM4ESMN1; SMN2AKR1C3AKR1C2
SCHEMBL5135534 0.85 KDM4E (0.61) ALDH1A1KDM4ESMN1; SMN2AKR1C3AKR1C2
SCHEMBL5135532 0.85 KDM4E (0.61) ALDH1A1KDM4ESMN1; SMN2AKR1C3AKR1C2
SCHEMBL27589914 0.84 ALDH1A1 (0.57) ALDH1A1KDM4EAKR1C3FAAHEPHX2
SCHEMBL31722975 0.84 TOP2A (0.63) ALDH1A1KDM4EAKR1C3AKR1C2POLM
SCHEMBL30886669 0.84 TOP2A (0.63) ALDH1A1KDM4EAKR1C3AKR1C2POLM
SCHEMBL27214652 0.84 TOP2A (0.63) ALDH1A1KDM4EAKR1C3AKR1C2POLM
SCHEMBL27214671 0.84 TOP2A (0.63) ALDH1A1KDM4EAKR1C3AKR1C2POLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10385013-B2 Micro/nano materials, products obtained by covalently modifying surface of micro/nano materials with hydrophilic materials, and method for making same CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) 2019-08-20 — — US disclosed
EP-3470443-A1 MICRO/NANOMATERIAL, PRODUCT THEREOF WITH SURFACE COVALENTLY MODIFIED WITH HYDROPHILIC MATERIAL, AND MANUFACTURING METHOD Chongqing Bolanying (BLY) Biotechnology Co., Ltd., China (CN) 2019-04-17 — — EP disclosed
US-20190077746-A1 MICRO/NANO MATERIALS, PRODUCTS OBTAINED BY COVALENTLY MODIFYING SURFACE OF MICRO/NANO MATERIALS WITH HYDROPHILIC MATERIALS, AND METHOD FOR MAKING SAME CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) 2019-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190077746-A1 MICRO/NANO MATERIALS, PRODUCTS OBTAINED BY COVALENTLY MODIFYING SURFACE OF MICRO/NANO MATERIALS WITH HYDROPHILIC MATERIALS, AND METHOD FOR MAKING SAME PHOSPHO1, PTMS, PAM ALDH1A1 1407/4885KDM4E 1621/4885SMN1; SMN2 4658/4885
US-10385013-B2 Micro/nano materials, products obtained by covalently modifying surface of micro/nano materials with hydrophilic materials, and method for making same PHOSPHO1, PTMS, PAM ALDH1A1 1407/4885KDM4E 1621/4885SMN1; SMN2 4658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback